Generation of an ICF Syndrome Model by Efficient Genome Editing of Human Induced Pluripotent Stem Cells Using the CRISPR System

• Main Authors: Izuho Hatada, Mika Kimura, Sumiyo Morita, Daiki Tamura, Takuro Horii
• Format: Article
• Language: English
• Published: MDPI AG 2013-09-01
• Series: International Journal of Molecular Sciences
• Subjects: CRISPR; iPS; Cas9; DNMT3B; ICF syndrome; genome engineering
• Online Access: http://www.mdpi.com/1422-0067/14/10/19774

Genome manipulation of human induced pluripotent stem (iPS) cells is essential to achieve their full potential as tools for regenerative medicine. To date, however, gene targeting in human pluripotent stem cells (hPSCs) has proven to be extremely difficult. Recently, an efficient genome manipulation technology using the RNA-guided DNase Cas9, the clustered regularly interspaced short palindromic repeats (CRISPR) system, has been developed. Here we report the efficient generation of an iPS cell model for immunodeficiency, centromeric region instability, facial anomalies syndrome (ICF) syndrome using the CRISPR system. We obtained iPS cells with mutations in both alleles of DNA methyltransferase 3B (DNMT3B) in 63% of transfected clones. Our data suggest that the CRISPR system is highly efficient and useful for genome engineering of human iPS cells.